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Background: Background
Sulbactam irreversibly inhibits the hydrolytic activity of
eta-lactamases. This compound is commercially available in com-
ination with either ampicillin or cefoperazone. In each instance,
he activity of the partner antibiotic against beta-lactamase pro-
ucing bacteria is restored. In this context the present study was
imed to ﬁnd out the antimicrobial susceptibility pattern of GNB
gainst cefaperazone-sulbactamand to correlate its activity against
ommonly used antimicrobials for treatment of GNB.
Methods: All Gram negative bacilli isolated from different
linical samples during a period of three months were tested
gainst cefaperazone-sulbactam, meropenem, ceftazidime, cefo-
axime, ceftriaxone, chloromphenicol, cotrimoxazole, ampicillin,
mikacin, gentamycin, nalidixic acid, ciproﬂoxacin, oﬂoxacin, nor-
oxacin, nitrofuratoin, aztreonam, carbenicillin, piperacillin and
obramycin using standard Kirby-Bauer disc diffusion antimicro-
ial susceptibility testing method. The susceptibility was recorded
s susceptible, intermediate susceptible and resistant by measur-
ng the zone of inhibition they showed. The data were recorded in
icrosoft excel sheet and analyzed in terms of percentage.
Results: A total of 406 Gram negative bacilli were isolated from
ifferent clinical samples. Majority of samples were from females
59.4%). The mean age of patient’s was 34.85. Out of 15 different
pecies of GNB, Escherichia coli was the frequent isolate (56.4%),
ollowed by Acinetobacter anitratus (17.5%), Klebsiella pneumoniae
9.1%) and Pseudomonas aeroginosa (5.9%). Almost all were isolated
rom urine (66.7%), pus (19.2%) and blood (7.9%). Ten percent of
solates were resistant to meropenem, which was the least resis-
ant drug, followed by cefaperazone-sulbactam (14.7%) followed
y amikacin (26.25%), chloromphenicol (38.46%). Isolates showed
igh degree of resistance against cephalosporins ranging from 73%
o 96%.
Conclusion: Gram negative bacilli showed high level of sus-
eptibility towards cefaperazone-sulbactam combination. It can be
onsidered as a cheap alternative in treatment of severe infections
aused by gram negative bacilli in our setting which would reduce
he cost of other expensive antimicrobials agents.
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Characterization of carbapenemase producing Enterobacteri-
aceae
B. Harish ∗, R. Srinivasan
Jawaharlal I nstitute of Medical Education & Research (JIPMER),
Pondicherry, India
Background: The increase in antibiotic resistance among gram-
negative bacteria is a notable example of how bacteria can procure,
maintain and express new genetic information that can confer
resistance to one or several antibiotics. An increasing number
of organisms are resistant to a number of antimicrobial agents.
The present study was undertaken to phenotypically character-
ize the carbapenemase producing Enterobacteriaceae. To isolate
and identify carbapenemase producing clinical isolates, determine
the antibiotic susceptibility patterns by MIC and characterize the
carbapenemase production phenotypically and genotypically.
Methods:The studywas carriedout in theDepartmentofMicro-
biology, JIPMER, Puducherry, India, with 50 Meropenem resistant
Enterobacteriaceae isolates from patients with different illnesses.
Identiﬁcation, antibiogram, Minimum Inhibitory Concentration,
Metallo beta-lactamase assay, Modiﬁed Hodge’s Test were per-
formed according to CLSI guidelines. Multiplex Polymerase chain
reaction was carried out for blaVIM, blaIMP, blaNDM, blaKPC. The
ampliﬁed DNA was analyzed by electrophoresis on a 1% agarose
gel.
Results: Out of 50 Meropenem resistant isolates belonging to
the family Enterobacteriaceae 54% were Klebsiella pneumonia and
48% of specimens were wound swabs, followed by tracheal aspi-
rates (20%). 68% of the isolates were from males. 40% of our isolates
were frompatients of age group 30 to 50 years. ByMIC, 90% of them
conferred high resistance to meropenem (4 to >128g/ml). 92% of
the isolates were MBL positive and 58% were modiﬁed Hodge’s test
positive. The presence of blaNDM and blaVIM were conﬁrmed by
Agarose gel electrophoresis.
Conclusion:Ourﬁndingemphasizes the increasing carbapenem
resistance and possible ramiﬁcations of their spread to other sim-
ilar bacteria. There is need to monitor the use of these high end
antibiotics both in hospital setup and general practice level.
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Comparison of nasal carriage of Staphylococcus aureus and its
antimicrobial resistance in various grades of medical students
S.H. Hashemi ∗, M.-Y. Alikhani, M.-A. Seif-Rabiee, S. Ahmadi
Hamedan University of Medical Sciences, Hamedan, Iran, Islamic
Republic of
Background: Staphylococcus aureushas been known as one of
the most common nosocomial pathogens worldwide. Methicillin-
